CVE-2016-8522

CVE-2016-8522 is a medium-severity vulnerability in Hp Diagnostics with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

A cross-site scripting vulnerability in HPE Diagnostics version 9.24 IP1, 9.26 , 9.26IP1 was found.

Frequently asked questions

What is CVE-2016-8522?
A cross-site scripting vulnerability in HPE Diagnostics version 9.24 IP1, 9.26 , 9.26IP1 was found.
How severe is CVE-2016-8522?
CVE-2016-8522 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2016-8522 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (61st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2016-8522?
CVE-2016-8522 primarily affects Hp Diagnostics. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2016-8522?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2016-8522 published?
CVE-2016-8522 was published on 2018-02-15 and last updated on 2026-06-17.

References

Affected products (3)

More vulnerabilities in Hp Diagnostics

All CVEs affecting Hp Diagnostics →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →